tiprankstipranks
Trending News
More News >
TME Pharma N.V. (FR:ALTME)
:ALTME
France Market
Advertisement

TME Pharma N.V. (ALTME) Technical Analysis

Compare
3 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
14Bullish
6Neutral
2Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
TME Pharma N.V.’s (ALTME) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting TME Pharma N.V. is a Sell.
TME Pharma N.V.’s (ALTME) 20-Day exponential moving average is 0.10, while TME Pharma N.V.’s (ALTME) share price is €0.11, making it a Buy.
TME Pharma N.V.’s (ALTME) 50-Day exponential moving average is 0.10, while TME Pharma N.V.’s (ALTME) share price is €0.11, making it a Buy.

TME Pharma N.V. (ALTME) Pivot Points

Sep 30, 2025, 10:20 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.09
0.09
0.10
0.10
0.10
0.11
0.11
Fibonacci
0.09
0.10
0.10
0.10
0.10
0.10
0.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

TME Pharma N.V. (ALTME) Moving Averages

Sep 30, 2025, 10:20 PM
Period
Simple
Exponential
MA5
0.10Buy
0.10Buy
MA10
0.10Buy
0.10Buy
MA20
0.10Buy
0.10Buy
MA50
0.11Buy
0.10Buy
MA100
0.10Buy
0.10Buy
MA200
0.08Buy
0.09Buy
TME Pharma N.V.’s (ALTME) 10-Day exponential moving average is 0.10, while TME Pharma N.V.’s (ALTME) share price is €0.11, making it a Buy.
TME Pharma N.V.’s (ALTME) 100-Day exponential moving average is 0.10, while TME Pharma N.V.’s (ALTME) share price is €0.11, making it a Buy.
TME Pharma N.V.’s (ALTME) stock price is €0.11 and TME Pharma N.V.’s (ALTME) 50-day simple moving average is 0.11, creating a Buy signal.
TME Pharma N.V.’s (ALTME) stock price is €0.11 and TME Pharma N.V.’s (ALTME) 100-day simple moving average is 0.10, creating a Buy signal.
TME Pharma N.V.’s (ALTME) stock price is €0.11 and TME Pharma N.V.’s (ALTME) 200-day simple moving average is 0.08, creating a Buy signal.

TME Pharma N.V. (ALTME) Technical Indicators

Sep 30, 2025, 10:20 PM
Name
Value
Implied Action
RSI (14)
57.20
Neutral
STOCH (9,6)
74.70
Neutral
STOCHRSI (14)
69.41
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
22.19
Neutral
Williams %R
-10.53
Sell
CCI (14)
93.73
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
69.93
Neutral
ROC
2.88
Buy
TME Pharma N.V.’s (ALTME) Relative Strength Index (RSI) is 57.20, creating a Neutral signal.
TME Pharma N.V.’s (ALTME) Trend Strength Indicator (ADX) is 22.19, creating a Neutral signal.
TME Pharma N.V.’s (ALTME) Commodity Channel Index (CCI) is 93.73, creating a Neutral signal.
TME Pharma N.V.’s (ALTME) Price Rate of Change (ROC) is 2.88, creating a Buy signal.

FAQ

Is ALTME a Buy, Hold, or Sell?
Based on ALTME’s technical indicators, ALTME is a Strong Buy.
    What is ALTME’s RSI (14)?
    ALTME’s RSI (14) is 57.20, which suggests ALTME is a Neutral.
      What is ALTME’s MACD?
      ALTME’s MACD is >-0.01, which suggests ALTME is a Sell.
        What is ALTME’s 5-day moving average?
        ALTME’s 5-day moving average is 0.10, which suggests ALTME is a Buy.
          What is ALTME’s 20-day moving average?
          ALTME 20-day moving average is 0.10, which suggests ALTME is a Buy.
            What is ALTME’s 50-day moving average?
            ALTME’s 50-day moving average is 0.11, which suggests ALTME is a Buy.
              What is ALTME’s 200-day moving average?
              ALTME’s 200-day moving average is 0.08, which suggests ALTME is a Buy.
                What is ALTME’s Williams % R (14)?
                ALTME’s Williams % R (14) is -10.53, which suggests ALTME is a Sell.
                  What is ALTME’s CCI (14)?
                  ALTME’s CCI (14) is 93.73, which suggests ALTME is a Neutral.
                    What is the share price of TME Pharma N.V.?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis